Properties (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
corporation
|
| gptkbp:acquisition |
gptkb:Avanir_Pharmaceuticals
Bristol-Myers_Squibb's_diabetes_business |
| gptkbp:awards |
Global_Health_&_Pharma_Awards
Best_Workplaces_in_Japan Pharma_Times_Awards Top_Employers_Japan |
| gptkbp:clinicalTrials |
conducts globally
|
| gptkbp:collaborations |
academic institutions
patient advocacy groups research organizations healthcare_providers |
| gptkbp:employees |
approximately 47,000
|
| gptkbp:focus |
mental health
oncology central nervous system disorders cardiovascular diseases biologics diagnostic imaging nutritional science |
| gptkbp:founded |
1964
|
| gptkbp:founder |
gptkb:Akihiko_Otsuka
|
| gptkbp:global_presence |
gptkb:Asia
gptkb:Latin_America gptkb:North_America Europe Middle_East |
| gptkbp:headquarters |
gptkb:Tokyo,_Japan
|
| https://www.w3.org/2000/01/rdf-schema#label |
Otsuka Group
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:innovation |
biotechnology advancements
digital health solutions new drug development patient-centered care initiatives |
| gptkbp:mission |
contribute to the health of people worldwide.
|
| gptkbp:operates_in |
over 20 countries
|
| gptkbp:partnerships |
gptkb:Mitsubishi_Tanabe_Pharma_Corporation
gptkb:Lundbeck |
| gptkbp:philanthropy |
gptkb:Otsuka_Foundation
|
| gptkbp:products |
medical devices
medications nutritional products |
| gptkbp:researchAndDevelopment |
over 20% of revenue
|
| gptkbp:revenue |
$11.5 billion (2020)
|
| gptkbp:subsidiary |
gptkb:Otsuka_Canada_Pharmaceutical_Inc.
gptkb:Otsuka_Pharmaceutical_Co.,_Ltd. gptkb:Otsuka_America_Pharmaceutical,_Inc. |
| gptkbp:sustainability |
environmental initiatives
governance practices social responsibility programs |
| gptkbp:website |
www.otsuka.com
|